Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy P Foster

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Antiviral Research|July 18, 2013
The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye modelJames M Hill, Ethan M Stern, Partha S Bhattacharjee, et al.
Journal of Biomedicine & Biotechnology|October 24, 2012
Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye diseasesJody M Webre, James M Hill, Nicole M Nolan, et al.
Virology Journal|October 2, 2012
HSV-1 latent rabbits shed viral DNA into their salivaJames M Hill, Nicole M Nolan, Harris E McFerrin, et al.
Journal of Virology|June 14, 2008
The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or genderJames M Hill, Melvyn J Ball, Donna M Neumann, et al.
Diabetes Care|December 20, 2023
Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 DiabetesTimothy P Foster, Laura M Jacobsen, Brittany Bruggeman, et al.
Science Translational Medicine|December 5, 2014
Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomesJames M Hill, Debra C Quenelle, Rhonda D Cardin, et al.
EMBO Reports|July 15, 2024
Novel immunomodulatory properties of adenosine analogs promote their antiviral activity against SARS-CoV-2Giulia Monticone, Zhi Huang, Peter Hewins, et al.
Journal for Immunotherapy of Cancer|November 11, 2025
Systemic mRNA vaccines elicit rapid immune activation in canine brain tumorsSheila Carrera-Justiz, Mahya Aghaee, Sadeem Qdaisat, et al.
Cell|May 2, 2024
RNA aggregates harness the danger response for potent cancer immunotherapyHector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Antiviral Research|July 18, 2013
The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye modelJames M Hill, Ethan M Stern, Partha S Bhattacharjee, et al.
Journal of Biomedicine & Biotechnology|October 24, 2012
Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye diseasesJody M Webre, James M Hill, Nicole M Nolan, et al.
Virology Journal|October 2, 2012
HSV-1 latent rabbits shed viral DNA into their salivaJames M Hill, Nicole M Nolan, Harris E McFerrin, et al.
Journal of Virology|June 14, 2008
The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or genderJames M Hill, Melvyn J Ball, Donna M Neumann, et al.
Diabetes Care|December 20, 2023
Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 DiabetesTimothy P Foster, Laura M Jacobsen, Brittany Bruggeman, et al.
Science Translational Medicine|December 5, 2014
Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomesJames M Hill, Debra C Quenelle, Rhonda D Cardin, et al.
EMBO Reports|July 15, 2024
Novel immunomodulatory properties of adenosine analogs promote their antiviral activity against SARS-CoV-2Giulia Monticone, Zhi Huang, Peter Hewins, et al.
Journal for Immunotherapy of Cancer|November 11, 2025
Systemic mRNA vaccines elicit rapid immune activation in canine brain tumorsSheila Carrera-Justiz, Mahya Aghaee, Sadeem Qdaisat, et al.
Cell|May 2, 2024
RNA aggregates harness the danger response for potent cancer immunotherapyHector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.
Pageof 5